Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Nov 2;18(11):e0287614. doi: 10.1371/journal.pone.0287614

How intramyocardial fat can alter the electric field distribution during Pulsed Field Ablation (PFA): Qualitative findings from computer modeling

Juan J Pérez 1, Ana González-Suárez 2,3,*
Editor: Kadiam Venkata Subbaiah4
PMCID: PMC10621855  PMID: 37917621

Abstract

Even though the preliminary experimental data suggests that cardiac Pulsed Field Ablation (PFA) could be superior to radiofrequency ablation (RFA) in terms of being able to ablate the viable myocardium separated from the catheter by collagen and fat, as yet there is no formal physical-based analysis that describes the process by which fat can affect the electric field distribution. Our objective was thus to determine the electrical impact of intramyocardial fat during PFA by means of computer modeling. Computer models were built considering a PFA 3.5-mm blunt-tip catheter in contact with a 7-mm ventricular wall (with and without a scar) and a 2-mm epicardial fat layer. High voltage was set to obtain delivered currents of 19, 22 and 25 A. An electric field value of 1000 V/cm was considered as the lethal threshold. We found that the presence of fibrotic tissue in the scar seems to have a similar impact on the electric field distribution and lesion size to that of healthy myocardium only. However, intramyocardial fat considerably alters the electrical field distribution and the resulting lesion shape. The electric field tends to peak in zones with fat, even away from the ablation electrode, so that ‘cold points’ (i.e. low electric fields) appear around the fat at the current entry and exit points, while ‘hot points’ (high electric fields) occur in the lateral areas of the fat zones. The results show that intramyocardial fat can alter the electric field distribution and lesion size during PFA due to its much lower electrical conductivity than that of myocardium and fibrotic tissue.

Introduction

Pulsed field ablation (PFA) is an interventional treatment method for arrhythmia and consists of applying short-duration high voltage pulses through ablation catheters. The PFA lesion is created by irreversible electroporation (IRE), which results in cell death [1]. As one of PFA’s potential benefits over other thermal ablation techniques (such as radiofrequency ablation, RFA), different tissues have been claimed to present different sensitivities to IRE and the myocardium has been shown to be the most susceptible [2]. However, besides this tissue-specific sensitivity (which is exclusively dependent on the response of the different cell types to the electric field), the tissue’s passive electrical properties and their relative spatial distribution will also affect the resulting distribution of the electric field. This issue is possibly a key factor when PFA is conducted on extremely heterogeneous substrates such as a healed infarction in the context of the catheter ablation of scar-mediated ventricular tachycardia (VT) and epicardial fat attached to the atrial wall in catheter ablation of atrial fibrillation (AF). The experimental data comparing PFA lesions on healthy myocardium and scar (healed infarction) tend to be rather scarce and are limited to pre-clinical models [3−5]. The preliminary results suggest that a superficial scar does not significantly impair PFA and creates lesion depths in healthy myocardium similar to adjacent healed endocardial scars (4.8 and 5.6 mm, respectively) [3]. Although the preliminary experimental data suggests that PFA may be superior to RFA in terms of being able to ablate viable myocardium separated from the catheter by collagen and fat [5], there is as yet no formal analysis based on physical laws that describes the process by which intramyocardial fat can affect the electric field distribution and alter the size of the PFA-induced lesion. Since fat is one order of magnitude less conductive than fibrotic and myocardial tissue (0.08 vs. 0.85 and 0.6 S/m, respectively), its presence could notably alter the electric field distribution and therefore the PFA-induced lesion size. Our objective was therefore to determine the electrical impact of the fat during PFA by means of computer modeling. This fat, for example, can be both intramyocardial fat deposited in a scar after a heart infarction or epicardial fat (i.e. between the heart and the pericardium).

Methods

Description of the computer model

Computer models were built considering a blunt-tip ablation catheter of 7-Fr 3.5-mm perpendicular to a ventricular endocardium, as proposed in Verma et al [6], inserted 0.5 mm into the tissue and surrounded by circulating blood, including a 2-mm epicardial fat layer and a 7 mm-thick cardiac wall (value based on that measured by CT angiography for the left ventricular mid-diastolic wall, 7.24 ±1.86 mm [7]). The rest of the model was filled with connective tissue composed of a mix of skeletal muscle and fat, as in Irastorza et al [8]. The ventricular wall comprised three types of tissue (viable myocardium, fibrous tissue and fat) following a spatial distribution based on a microscopic image reported in Sasaki et al [9] and used in a previous radiofrequency ablation computer modeling study [10]. For the sake of computational simplicity, the model volume was built by rotating this image over a symmetry axis representing the longitudinal catheter axis (see Fig 1). High intensity voltage pulses were applied in monopolar mode to the endocardium, as in González-Suárez et al [11].

Fig 1.

Fig 1

A: Model geometry in which the volume was created by rotating a 2D model around the catheter axis. B: Detail of the scar included in the ventricular wall (case of fat deposition in the scar).

Governing equations

Laplace’s Equation was used to compute the electrical potential ϕ [11]

(σϕ)=0 (1)

where σ is the electrical conductivity of the material. The electrical field distribution E was calculated by E = −∇ϕ, while J the current density vector was calculated using the Ohm Law in its vector form:

J=σE (2)

We ignored the transient cellular response (membrane charging), as in previous cardiac PFA computer modeling studies [11−14]. This phenomenon takes a very short time and has no relevant effect on the PFA-induced lesion size. The model was numerically solved by the Finite Element Method on ANSYS software (ANSYS, Canonsburg, PA, USA). The ablation electrode voltage value was set to obtain delivered currents of 19, 22 and 25 A, while the outer boundaries were set to zero volts to mimic the monopolar mode. We set the current values as in the Centauri System (Galaxy Medical, CA, USA), a commercially available PFA generator that can work with focal cardiac ablation catheters such as the one modeled in this study. This meant that the applied voltage really varied in a range of ~200 V, according to the tissue’s electrical characteristics. Instead of setting current, other PFA systems set the peak voltage value, so that the current depends on the tissue’s electrical characteristics. The choice of setting current or voltage was irrelevant in the context of our study, which did not aim to predict the PFA-induced lesions created with a specific PFA generator, but to mimic the impact of intramyocardial fat on the electric field distribution.

Modeling the spatial distribution of tissues involved

Six models were built to consider the variability of the spatial distributions of myocardium, fat and fibrosis (see Fig 2). The first two models were based on a homogeneous cardiac wall (i.e. without scar or intramyocardial fat): A) homogeneous healthy myocardium with an epicardial fat, B) homogeneous healthy myocardium without an epicardial fat layer (replaced by connective tissue). The four other models included scar tissue: C) the original model published in [10] without considering fat deposition, i.e. replacing fat by fibrotic tissue, D) as in C by including fat deposition, E) as in C but including a channel of healthy myocardium just under the ablation electrode, and F) a blocked model, in which the subendocardial myocardium was replaced by fibrotic tissue. Note that there is connective tissue under these layers, as shown in Fig 1. Although these distributions are specific examples of the possibly infinite number of distributions (and thus may appear somewhat arbitrary), they mimic clinically relevant situations in the context of scar-mediated VT ablation. The channel model was intended to mimic the scar de-channeling technique and consisted of ablating only the conduction channel entrances rather than an carrying out an extensive ablation [15]. The blocked model was intended to mimic a VT ablation with a deep arrhythmogenic focus and the fibrosis occupies almost all the space below the electrode (with very little subendocardial healthy myocardium). These six models together offer a representative sample for the analysis of the impact of fat on the electric field distribution. While models A and B are relevant in the context of PFA on the atrial wall to treat AF, models C−F are important in the context of PFA on substrates with intramyocardial fat, which could be related to a post-myocardial infarction scar.

Fig 2. Details of the modeled ventricular walls consisting of different tissues: Myocardium, fibrotic tissue and fat.

Fig 2

Tissue electrical properties

The change in σ induced by PFA was modeled by a sigmoid function [16] that depended on the electric field magnitude σ(E) as follows:

σ(E)=σ0+σ1σ01+10e(|E|58000)3000 (3)

where σ0 and σ1 are the pre- and post-electroporation electric conductivities, respectively.

The values of σ0 and σ1 are thus related to the presence or absence of pores in the cell membrane. Although there are experimental studies on how electrical conductivity changes prior to and after PFA for tissues such as kidney [17] and liver [18], to our knowledge there are none for tissues involved in cardiac PFA, so that we had to make assumptions based on the current flow through the tissues and whether or not the cell membrane was electroporated. Prior to PFA, i.e. before the pores have been created, electric current flows only through the extracellular space as when the tissue is subjected to low frequency electrical excitation and the cell membrane acts as an electrical insulator. The σ0 values are thus those measured at frequencies below beta dispersion (i.e. when the cell membrane impedes the current flow). In practical terms, σ remains more or less constant between 1 and 10 kHz and increases at higher frequencies due to the electrical current flowing not only through the extracellular space but also through the cytoplasm. Following this reasoning, we chose the σ0 and σ1 tissue values as follows:

  1. For healthy myocardium, we used the values reported in two in vivo experimental studies on a pig model [19, 20] in which σ was measured for healthy and scar ventricular tissue in a broad range of frequencies (1−1000 kHz). These results showed that between 1 and 10 kHz, the σ value was approximately 0.4±0.1 S/m, while at 1000 kHz, it rose to 0.6±0.1 S/m [19, 20]. This latter value is identical to that reported by Tsai et al [21] at 1 MHz, also measured in in vivo pig ventricle: 0.6±0.05 S/m. The two values 0.4 and 0.6 S/m were therefore used as the pre- (σ0) and post-PFA (σ1) electrical conductivity for healthy myocardium.

  2. The scar (healed myocardium after infarction) contains very few surviving cells. In fact, the densely infarcted zone is composed almost exclusively of collagen [22]. This is reflected in the lack of a capacitive (i.e. frequency-dependent) response. In other words, there is no beta dispersion [19, 20, 22]. This means that for scar tissue, σ0 and σ1 can be considered to be identical, although there is experimental evidence suggesting that fibrotic scar is more conductive than healthy myocardium: [19, 20, 22, 23]. Salazar et al [20] and Cinca et al [19] reported values of around 0.8 and 0.9 S/m, respectively, while Schwartzman et al [22] obtained a value of 0.44 S/m at 40 kHz, as opposed to a lower value for the healthy tissue (0.14 S/m). Likewise, Fallert et al reported a value of 1.02 S/m at 15 kHz, as opposed to a lower value for healthy tissue (0.53 S/m) [23]. This tendency of fibrotic tissue to be more conductive has also been found in other organs such as rat liver, in which fibrous tissue (induced by a weekly intraperitoneal injection of dimethylnitrosamine in 45 male Sprague–Dawley rats) had an electrical conductivity ≥12% compared to that of normal control rats [24]. A value of 0.85 S/m was thus considered for fibrotic tissue, regardless of the electric field value.

  3. We used the value of 0.08 S/m for fat reported by Gabriel et al [25], which was obtained from an in vivo pig model. Since this value was found to stay more or less constant within a broad frequency (10 kHz−1 MHz) [26], we assumed that σ0 = σ1 = 0.08 S/m. The tissue beyond the ventricular wall (which completed the limited domain model [11]), was assumed to be a mix of skeletal muscle and fat, as suggested by the CT images, with a ratio of fat varying from 20 to 80% [9]. Since this tissue is really far from the ablation electrode and hence considered to be unaffected by the electric field at any time, its electrical conductivity was that of the low frequency zone, i.e. lower beta dispersion. The electrical conductivity of skeletal muscle at low frequency was assumed to be 0.15 S/m [25]. The electrical conductivity of the tissue beyond the ventricular wall was thus σ0 = σ1 = 0.115 S/m (assuming a mix ratio of 50% of fat).

  4. The blood circulation inside the ventricle cools the pool of blood cells around the ablation electrode. Even considering a broad range of possible blood velocities, e.g. from 0.1 to 100 cm/s, a blood cell subjected to the electric field around the ablation electrode will only have moved 0.1−100 μm during the application of a voltage pulse of 100 μs and less for shorter pulses. In other words, the blood cells surrounding the ablation electrode can also be assumed to be electroporated. However, we considered the same electrical conductivity of 0.6 S/m before and after PFA, since this value has been found to be more or less constant within a wide range of frequencies (100 Hz−1 MHz) [25].

Table 1 summarizes the data of electrical conductivity used in the model for the tissues studied.

Table 1. Electrical conductivities (S/m) of the tissues involved in the model pre- (σ0) and post-electroporation (σ1).

Tissue σ0 σ1
Myocardium 0.4 0.6
Scar 0.85 0.85
Fat 0.015 0.015
Blood 0.6 0.6

Assessment of the PFA-induced lesion size

An electric field value of 1000 V/cm was used as the irreversible electroporation lethal threshold, as in other previous PFA computer modeling studies [14, 27] and suggested by a recent experimental study based on a suspension in vitro model for cardiac cells [28]. We only plotted the PFA-induced lesion in the myocardium, since it is really the target of the PFA, so that no lethal threshold was considered for the other fibrotic and fat tissues.

Results

Fig 3 shows the electrical field distributions for the six considered cases at a current of 22 A. There was very little difference in the computation time of the six models. Table 2 gives the PFA lesion size (depth and surface width) for the different ventricular wall models and three current values. Note that the lesion size was computed as the extension of the 1000 V/cm isoline, even though it was on tissue other than myocardium, i.e. occupying an area outside the ablation target. In general, the lesion size was similar for all the models except for the one with a fat deposition within the scar (Fig 3D), in which case the lesion was ~1 mm deeper than without this factor. As this was possibly due to the specific fat location and distribution, this result should not be valued quantitatively, but qualitatively. The most important finding is therefore the ability of the fat deposited in the scar to significantly alter the electric field distribution, something that is not found in fibrotic tissue. In fact, with fat present in the scar, the lesion depth did not change when the electric current was raised (Fig 4), and the deepest lesion limit (1000 V/cm isoline) always coincided with the lower fat boundary. The presence of fat also tends to widen the lesion, but this possibly depends on the specific shape of the deposit, since the lesion tends to follow the limits of the fat itself.

Fig 3. Electric field distributions for the different cases considered (red color for >1000 V/cm and blue color for <490 V/cm) with 22 A current.

Fig 3

Lesion depth and surface width (in mm) induced by irreversible electroporation was computed with the 1000 V/cm isoline. In case D, the contour of the largest area of fat deposited in the scar is highlighted by a continuous thick white line.

Table 2. Lesion sizes computed by 1000 V/cm isoline (D: Depth; SW: Surface width) for different delivered current and considered cases of ventricular wall.

Applied current
19 A 22 A 25 A
Model D (mm) SW (mm) D (mm) SW (mm) D (mm) SW (mm)
A) Homogeneous (no scar) 3.40 9.62 3.65 10.48 3.91 11.22
B) Homogeneous (no epicardial fat layer) 3.40 9.56 3.71 10.44 3.97 11.22
C) Scar without fat deposition 3.11 8.98 3.37 9.72 3.60 10.44
D) Scar with fat deposition 4.59 9.74 4.59 11.00 4.59 12.44
E) Channel in scar 3.11 9.08 3.35 9.88 3.58 10.60
F) Blocked 3.20 9.04 3.47 9.78 3.68 10.5

Fig 4. Lesion depths induced by irreversible electroporation (computed with the 1000 V/cm isoline) for different delivered currents and for the six considered cases.

Fig 4

The lines showing the “channel in scar” and “scar without fat deposition” are almost identical.

The alteration of the electric field caused by the presence of fat implied low electric field values at the current’s entry and exit points in the fat zone (i.e. ‘cold points’ in terms of electric field), while high electric field values (i.e. electric field ‘hot points’) appeared in the fat’s lateral areas (see Fig 5).

Fig 5.

Fig 5

A: Electric field distribution for heterogeneous model with fat deposition (22 A current). Detail of electric field (B) and electric field vector (C) around fat zones, showing ‘cold points’ and ‘hot points’ since electrical current tends to bypass fat due to its lower electrical conductivity.

The effect of the different ventricular wall models barely affected the voltage needed to deliver a given current. For example, the voltage varied between 1960 V (blocked model) to 2150 V (heterogeneous with fat deposition) at 22 A. The lesions became deeper and wider as the current was increased (except in the case of a scar with fat deposition), with an almost linear trend of 0.08 mm/A in depth and 0.25 mm/A in width.

Discussion

The impact of fat on the electric field distribution and lesion shape in the myocardium (target) was analyzed by computer modeling. A set of the different spatial configurations of these tissues in the ventricular wall was considered to generate results that could be applied in clinical practice. Note that cases without a scar and intramyocardial fat can also be used to illustrate the impact of epicardial fat during PFA of atrial fibrillation.

Qualitative description of the electrical impact of intramyocardial fat

We found that the presence of fibrotic tissue has little impact on the electric field distribution and lesion size compared to that of healthy myocardium only, which has already been suggested by experimental data [3]. However, we also found that the fat inside the scar significantly alters the electrical field distribution and the resulting lesion shape. To be more precise, the electric field tends to be higher in fat than in other tissues, even when the fat is far from the ablation electrode, so that ‘cold points’ (i.e. with a low electric field) appear around the fat electrical current entry and exit points, while ‘hot points’ (i.e. high electric field) appear in the lateral areas.

Our findings on the important role of intramyocardial fat during PFA are closely connected to the heterogeneity of the tissues in the ventricular scar in terms of electrical conductivity, with healthy myocardium and fibrosis offering similar values (0.6 and 0.85 S/m), while fat has a significantly lower value (0.08 S/m), which means the fat acts as an ‘attractor’ of the electric field, where it tends to be especially high. This ‘attraction’ seriously alters the electric field distribution in the contiguous tissues surrounding the fat.

This alteration is characterized by zones with a low electric field (‘cold points’) around the fat at the points where the electric current enters and exits and in the zones with a high electric field (‘hot points’) in the lateral areas (see Fig 5B). From the point of view of spatial distribution, this is due to the fact that the electric currents try to avoid the less conductive areas, such as those in the direction of the electric field vector in Fig 5C (current density vector has the same direction as the electric field when displacement currents are neglected, as shown in Eq (3)). The alteration of the electric field around structures surrounded by tissues with different electrical conductivity has already been described in the context of PFA. In essence, two circumstances can occur: 1) a structure with lower electrical conductivity than the surrounding tissue (as in our case with fat surrounded by fibrosis) or 2) a structure with higher electrical conductivity than the surrounding tissue (as occurs in blood vessels surrounded by fat [29] or by liver parenchyma [30]). In the former case, the ‘cold points’ appear at the current’s entry and exit points (since it tries to avoid the less conductive structure), while in the latter case they appear at the sides, and ‘hot points’ occur at the current entry and exit points (since it tends to flow through the more conductive structure). This phenomenon has been computationally studied in the context of Low-Energy Defibrillation (LED), which is based on the ‘Virtual Electrode’ (VE) effect, in which the conductivity heterogeneities cause localized regions of depolarization and adjacent hyper-polarization [31]. This is caused by the electrical heterogeneity of the cardiac wall anatomy and the electrical boundary conditions to be applied between the interfaces with very different electrical conductivity values, as between fat and myocardium. In short, and as can be seen in Fig 6, by assuming that the displacement current is negligible compared to the conductive current, the current density J and electric field E vectors are simply related to each other by means of Ohm’s Law in vector form, J = σ·E. The two first electrical boundary conditions come from applying Maxwell’s Equations at the interface: 1) the tangential component of E (Et) is continuous across the interface, i.e. the tangential value is the same in the two adjoining zones Et,myo = Et,fat; and 2) the normal (i.e. perpendicular) component of J (Jn) is the same in the two adjoining zones, i.e. Jt,myo = Jt,fat. By applying Ohm’s Law to the second boundary condition, we find that the normal component of E (En) is not continuous across the interface and is governed by the following equation: σmyo·En,myo = σfat·En,fat, i.e by the ratio between the fat and myocardium electrical conductivities. Since σfat<<σmyo, En,fat>>En,myo, resulting in a higher electric field vector E in fat.

Fig 6. Mathematical justification of the boundary conditions of normal and tangential components (in red) of the electric field vector E at the interface between myocardium and fat.

Fig 6

As a result, the normal component of E in the fat is much greater than the normal component in myocardium, which implies that the electrical field vector is much greater in fat.

In practical terms, we found that under certain circumstances such as those shown in Fig 2D, the fat could prevent damage to deeper tissues, maintaining a constant depth of 4.59 mm, despite current value increases from 19 to 25 A (see Fig 4). And not only deeper tissues, the mere presence of fat in the path of the electric current implies that contiguous tissues, even when they are closer to the surface, i.e. closer to the ablation electrode, could be subjected to a lower electric field. In other words, the electrical field tends to peak in fat zones. This can be clearly seen in all the cases in which the electric field was higher in the epicardial fat layer than in the contiguous myocardium, despite being deeper (see Fig 3A, 3C–3F). In the case without an epicardial fat layer we found the same phenomenon, since the connective tissue (see Fig 3B) was also considered to be less conductive than myocardium (0.11 vs. 0.6 S/m). The physical explanation for this is that the electric field is the gradient vector of the voltage, as mathematically expressed in Eq (2). The gradient vector represents the direction and magnitude of the spatial variation of a scalar magnitude, voltage in this case, so that despite the fact that the voltage (electric potential) from the electrode (at ~2 kV) to the dispersive electrode (at 0 V) gradually decreases, as could be expected, this decrease can be uneven according to the electrical conductivity of the tissues and is more abrupt in less conductive tissues such as fat (see Fig 7A). This more abrupt change results in a higher electric field value and is the reason why we can find points far from the ablation electrode with higher electric field values than other closer points (see Fig 7B).

Fig 7.

Fig 7

Variation of voltage (A) and electric field (B) along the axis under the electrode, from the tissue surface (0 mm, inside the electrode) to a depth of 15 mm, for two ventricular walls: homogeneous myocardium (i.e. without scar), and scar with fat deposition. Note that the voltage drop (i.e. how fast it falls along the axis) is greater across the less conductive tissue (fat), which results in electric field values even higher than those in tissues closer to the ablation electrode (myocardium and fibrosis).

Comparison with experimental results and clinical implications

There are not yet enough published experimental data on PFA-induced lesion sizes with which to compare our computational findings. The preliminary results suggesting that PFA is able to ablate viable myocardium separated from the catheter by collagen and fat [5, 32] could be considered as not in line with our findings, since our results show that the fat concentrates high electric field values and prevents the lesion from reaching outlying tissues. However, our results do not show that the presence of fat always has a negative impact. In fact, the lesion was deeper and wider in the specific model considered with the presence of fat (as shown in Fig 3). What we have learned from our study is the way fat alters the surrounding electric field. The clinical implication in terms of PFA effectiveness will depend mainly on the spatial distribution of the fat and its relative position with respect to the ablation electrode and the ablation target. Note that the arrhythmogenic target could be in a ‘hot or cold’ spot in terms of the electric field, according to the above-mentioned factors, which do not seem to be easy to control in an experimental setup.

Also, there is currently a consensus that, since the different commercially available PFA generators work with very different undisclosed energy distribution protocols (electrode design, waveform and frequency, polarity, etc.), the experimental results obtained with a given setup are only valid for that specific case [33], making comparisons much more complicated. In this regard, the few published experimental studies used different technologies to that modeled by us: while we modeled a standard-tip catheter, Younis et al [5] conducted monopolar PFA with a relatively large spherical electrode (9-mm diameter) and Higuchi et al [32] conducted bipolar PFA with 4 band electrodes on an 8Fr catheter.

Apart from these differences, the worth of our study lies more in the qualitative description based on physical laws of how intramyocardial fat can alter the electric field distribution, regardless of the generator or protocol used. The concepts derived from our results on how fat alters the electric field should thus be valid, regardless of the PFA technical details, and our results do in fact suggest that some of these details related to the relative position of the fat and ablation electrode (such as electrode design and polarity) are possibly relevant to determine whether the presence of fat can favor or limit the lesion size.

Finally, since our results suggest that the position of ‘hot and cold points’ in terms of electric field depends mainly on the fat distribution, it is important to note that the distribution is highly dependent on the specific disease being treated. While fatty infiltration tends to be compact in the case of myocardial infarction, it is more disperse in arrhythmogenic right ventricular cardiomyopathy [34]. Our mathematical framework is based on valid physical laws (Laplace’s Equation) regardless of the specific fat distribution considered. In this regard, although our model of infiltrated fat in the scar (Fig 2D) was initially inspired by a histological image derived from a post-infarction scar [9], it also includes specific zones in which the fat appears patchy, i.e. more disperse and separated by fibrotic tissue (see detail in Fig 5A). It is precisely around these small zones of scattered fat in which the electric field is significantly altered, depending on the relative position of the ablation electrode, or what is the same, on the direction of the electric current, as shown in Fig 5B. In conclusion, what our results suggest is that when the fat is in the form of isolated areas such as those found in some non-ischemic cardiomyopathies, the alternation of ‘hot and cold points’ in the contiguous tissue in terms of electric field strength could compromise the efficacy of the PFA of arrhythmogenic foci around the fat.

Limitations

This study only considered a specific ablation catheter with a 3.5-mm blunt tip, placed perpendicular to the tissue and inserted 0.5 mm, while only some specific spatial arrangements of the fat, fibrosis and myocardium were considered. This means that the sizes of the PFA-induced lesions predicted by the model cannot be directly compared to those from pre-clinical studies, especially due to the lethal threshold we used (1000 V/cm), possibly being dependent on the specific waveform, voltage setting and the number of applications. Despite this, we consider that this method is able to demonstrate the impact of intramyocardial fat on the electrical field distribution during PFA.

In the study we ignored the thermal side effects. Although they are theoretically negligible, since PFA is a nonthermal ablation technique, some heating can be expected to be induced by the electric field and current density. Even assuming that a temperature rise would also raise the electrical conductivity and somehow alter our results, the impact is probably minimum, since: 1) the fat’s temperature coefficient is not very different to the rest of the tissues (1.6−1.7%/°C) [35], suggesting that the effect of heating on the electrical conductivity will be similar for all the tissues, and 2) the fat’s tendency to show high electric field values, E also implies low values of current density J, suggesting that Joule heating (J·E) is not expected to be different in fat to that of other tissues, as has been found in RFA [10].

We also ignored the anisotropy of the electrical conductivity. Although electrical anisotropy has been suggested to be important in fibrous muscles such as skeletal and cardiac, it only seems to be relevant at a low frequency, i.e. when the cell membrane plays an important role in the electrical terms, but not at a high frequency, when it is already virtually bypassed. In this regard, Tsai et al [21] observed that ventricular tissue at 10 kHz was slightly more conductive in the transverse than the longitudinal direction: 0.4 vs. 0.36 S/m, respectively. This implies a degree of anisotropy of only 11% in terms of electrical conductivity at low frequencies, which probably has a minimal impact on ablation modeling. Differences of around 26% were reported by Gabriel et al [25] at 40–70 Hz in three different directions, which implies an anisotropy ratio of 1.27, and much lower than those assumed by Zang et al [13] (between 1.43 and 6.25) in a computational PFA modeling study, who did find differences in terms of the lesion size induced by PFA between an isotropic and anisotropic model.

However, although anisotropy of the electrical conductivity has been suggested to be a relevant characteristic in the electroporation of breast tumors [36], there are still no experimental data to support a degree of anisotropy in cardiac tissue high enough to significantly affect the electric field distribution during PFA. It should be noted that this does not mean that anisotropy has no impact on the electric field distribution and PFA-induced lesion size, but rather that its effect is possibly not important in the context of our objective of showing how the presence of fat alters the electric field distribution.

Finally, we used a limited-domain model, i.e. only fragments of tissue around the ablation electrode were included, instead of a realistic reconstruction of the heart. This is a valid approach since the electric field values are practically negligible outside the limits considered, as shown in Fig 7.

Conclusions

While the presence of fibrotic tissue has little impact on the electric field distribution and lesion size compared to that in healthy myocardium, intramyocardial fat significantly alters the electrical field distribution and the resulting lesion shape. In particular, the electric field tends to be higher in fat, even when the fat is farther from the ablation electrode. ‘Cold points’ with a low electric field appear around the fat at the electrical current’s entry and exit points, while ‘hot points’ are formed in the lateral areas with a high electric field.

In practical terms, the positive or negative effect of fat on the PFA-induced lesion size will depend on the spatial distribution of the fat and its position relative to the electrode, making it impossible to draw a general conclusion on the presence of fat, while the same time suggesting the value of computational modeling as a predictive tool for planning PFA on substrates with high fat content.

Supporting information

S1 Data

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

Funded by the Spanish Ministerio de Ciencia e Innovación / Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) with Grant number PID2022-136273OB-C31 and PID2022-136273OA-C33. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Caluori G, Odehnalova E, Jadczyk T, Pesl M, Pavlova I, Valikova L, et al. AC Pulsed Field Ablation Is Feasible and Safe in Atrial and Ventricular Settings: A Proof-of-Concept Chronic Animal Study. Front Bioeng Biotechnol. 2020. Dec 3;8:552357. doi: 10.3389/fbioe.2020.552357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wittkampf FHM, van Es R, Neven K. Electroporation and its Relevance for Cardiac Catheter Ablation. JACC Clin Electrophysiol. 2018. Aug;4(8):977–986. doi: 10.1016/j.jacep.2018.06.005 [DOI] [PubMed] [Google Scholar]
  • 3.Kawamura I, Reddy VY, Wang BJ, Dukkipati SR, Chaudhry HW, Santos-Gallego CG, et al. Pulsed Field Ablation of the Porcine Ventricle Using a Focal Lattice-Tip Catheter. Circ Arrhythm Electrophysiol. 2022. Sep;15(9):e011120. doi: 10.1161/CIRCEP.122.011120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Im SI, Higuchi S, Lee A, Stillson C, Buck E, Morrow B, et al. Pulsed Field Ablation of Left Ventricular Myocardium in a Swine Infarct Model. JACC Clin Electrophysiol. 2022. Jun;8(6):722–731. doi: 10.1016/j.jacep.2022.03.007 [DOI] [PubMed] [Google Scholar]
  • 5.Younis A, Zilberman I, Krywanczyk A, Higuchi K, Yavin HD, Sroubek J, et al. Effect of Pulsed-Field and Radiofrequency Ablation on Heterogeneous Ventricular Scar in a Swine Model of Healed Myocardial Infarction. Circ Arrhythm Electrophysiol. 2022. Oct;15(10):e011209. doi: 10.1161/CIRCEP.122.011209 [DOI] [PubMed] [Google Scholar]
  • 6.Verma A, Neal R, Evans J, Castellvi Q, Vachani A, Deneke T, et al. Characteristics of Pulsed Electric Field Cardiac Ablation Porcine Treatment Zones with a Focal Catheter. J Cardiovasc Electrophysiol. 2022. Nov 6. doi: 10.1111/jce.15734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Walpot J, Juneau D, Massalha S, Dwivedi G, Rybicki FJ, Chow BJW, et al. Left Ventricular Mid-Diastolic Wall Thickness: Normal Values for Coronary CT Angiography. Radiol Cardiothorac Imaging. 2019. Dec 19;1(5):e190034. doi: 10.1148/ryct.2019190034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Irastorza RM, Maher T, Barkagan M, Liubasuskas R, Pérez JJ, Berjano E, et al. Limitations of Baseline Impedance, Impedance Drop and Current for Radiofrequency Catheter Ablation Monitoring: Insights from In silico Modeling. J Cardiovasc Dev Dis. 2022. Oct 3;9(10):336. doi: 10.3390/jcdd9100336 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sasaki T, Calkins H, Miller CF, Zviman MM, Zipunnikov V, Arai T, et al. New insight into scar-related ventricular tachycardia circuits in ischemic cardiomyopathy: Fat deposition after myocardial infarction on computed tomography—A pilot study. Heart Rhythm 2015;12:1508–1518. doi: 10.1016/j.hrthm.2015.03.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pérez JJ, D’Avila A, Aryana A, Trujillo M, Berjano E. Can Fat Deposition After Myocardial Infarction Alter the Performance of RF Catheter Ablation of Scar-Related Ventricular Tachycardia?: Results from a Computer Modeling Study. J Cardiovasc Electrophysiol. 2016. Aug;27(8):947–52. doi: 10.1111/jce.13006 [DOI] [PubMed] [Google Scholar]
  • 11.González-Suárez A, Irastorza RM, Deane S, O’Brien B, O’Halloran M, Elahi A. Full torso and limited-domain computer models for epicardial pulsed electric field ablation. Comput Methods Programs Biomed. 2022. Jun;221:106886. doi: 10.1016/j.cmpb.2022.106886 [DOI] [PubMed] [Google Scholar]
  • 12.García-Sánchez T, Amorós-Figueras G, Jorge E, Campos MC, Maor E, Guerra JM, et al. Parametric Study of Pulsed Field Ablation With Biphasic Waveforms in an In Vivo Heart Model: The Role of Frequency. Circ Arrhythm Electrophysiol. 2022. Oct;15(10):e010992. doi: 10.1161/CIRCEP.122.010992 [DOI] [PubMed] [Google Scholar]
  • 13.Zang L, Gu K, Ji X, Zhang H, Yan S, Wu X. Effect of Anisotropic Electrical Conductivity Induced by Fiber Orientation on Ablation Characteristics of Pulsed Field Ablation in Atrial Fibrillation Treatment: A Computational Study. J Cardiovasc Dev Dis. 2022. Sep 22;9(10):319. doi: 10.3390/jcdd9100319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.González-Suárez A, O’Brien B, O’Halloran M, Elahi A. Pulsed electric field ablation of epicardial automatic ganglia: Computer analysis of monopolar electric field across the tissues involved. Bioengineering 2022. Nov;9(12):731. doi: 10.3390/bioengineering9120731 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Berruezo A, Fernández-Armenta J, Andreu D, Penela D, Herczku C, Evertz R, et al. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythm Electrophysiol. 2015. Apr;8(2):326–36. doi: 10.1161/CIRCEP.114.002386 [DOI] [PubMed] [Google Scholar]
  • 16.Sel D, Cukjati D, Batiuskaite D, Slivnik T, Mir LM, Miklavcic D. Sequential finite element model of tissue electropermeabilization. IEEE Trans Biomed Eng. 2005;52(5):816–27. doi: 10.1109/TBME.2005.845212 [DOI] [PubMed] [Google Scholar]
  • 17.Neal RE 2nd, Garcia PA, Robertson JL, Davalos RV. Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning. IEEE Trans Biomed Eng. 2012. Apr;59(4):1076–85. doi: 10.1109/TBME.2012.2182994 [DOI] [PubMed] [Google Scholar]
  • 18.Zhao Y, Bhonsle S, Dong S, Lv Y, Liu H, Safaai-Jazi A, et al. Characterization of Conductivity Changes During High-Frequency Irreversible Electroporation for Treatment Planning. IEEE Trans Biomed Eng. 2018. Aug;65(8):1810–1819. doi: 10.1109/TBME.2017.2778101 [DOI] [PubMed] [Google Scholar]
  • 19.Cinca J, Warren M, Rodríguez-Sinovas A, Tresànchez M, Carreño A, Bragós R, et al. Passive transmission of ischemic ST segment changes in low electrical resistance myocardial infarct scar in the pig. Cardiovasc Res. 1998. Oct;40(1):103–12. doi: 10.1016/s0008-6363(98)00145-x [DOI] [PubMed] [Google Scholar]
  • 20.Salazar Y, Bragos R, Casas O, Cinca J, Rosell J. Transmural versus nontransmural in situ electrical impedance spectrum for healthy, ischemic, and healed myocardium. IEEE Trans Biomed Eng. 2004. Aug;51(8):1421–7. doi: 10.1109/TBME.2004.828030 [DOI] [PubMed] [Google Scholar]
  • 21.Tsai JZ, Will JA, Hubbard-Van Stelle S, Cao H, Tungjitkusolmun S, Choy YB, et al. In-vivo measurement of swine myocardial resistivity. IEEE Trans Biomed Eng. 2002. May;49(5):472–83. doi: 10.1109/10.995686 [DOI] [PubMed] [Google Scholar]
  • 22.Schwartzman D, Chang I, Michele JJ, Mirotznik MS, Foster KR. Electrical impedance properties of normal and chronically infarcted left ventricular myocardium. J Interv Card Electrophysiol. 1999. Oct;3(3):213–24. doi: 10.1023/a:1009887306055 [DOI] [PubMed] [Google Scholar]
  • 23.Fallert MA, Mirotznik MS, Downing SW, Savage EB, Foster KR, Josephson ME, et al. Myocardial electrical impedance mapping of ischemic sheep hearts and healing aneurysms. Circulation. 1993. Jan;87(1):199–207. doi: 10.1161/01.cir.87.1.199 [DOI] [PubMed] [Google Scholar]
  • 24.Kim JW, Kim HB, Hur YH, Choi BK, Katoch N, Park JA, et al. MR-Based Electrical Conductivity Imaging of Liver Fibrosis in an Experimental Rat Model. J Magn Reson Imaging. 2021. Feb;53(2):554–563. doi: 10.1002/jmri.27275 [DOI] [PubMed] [Google Scholar]
  • 25.Gabriel C, Peyman A, Grant EH. Electrical conductivity of tissue at frequencies below 1 MHz. Phys Med Biol. 2009. Aug 21;54(16):4863–78. doi: 10.1088/0031-9155/54/16/002 [DOI] [PubMed] [Google Scholar]
  • 26.Kangasmaa O, Laakso I. Estimation method for the anisotropic electrical conductivity of in vivo human muscles and fat between 10 kHz and 1 MHz. Phys Med Biol. 2022. Oct 13. doi: 10.1088/1361-6560/ac9a1e [DOI] [PubMed] [Google Scholar]
  • 27.Gómez-Barea M, García-Sánchez T, Ivorra A. A computational comparison of radiofrequency and pulsed field ablation in terms of lesion morphology in the cardiac chamber. Sci Rep. 2022. Sep 27;12(1):16144. doi: 10.1038/s41598-022-20212-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Avazzadeh S, O’Brien B, Coffey K, O’Halloran M, Keane D, Quinlan LR. Establishing irreversible electroporation electric field potential threshold in a suspension in vitro model for cardiac and neuronal cells. J Clin Med. 2021. Nov 22;10(22):5443. doi: 10.3390/jcm10225443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.González-Suárez A, Pérez JJ, O’Brien B, Elahi A. In silico modelling to assess the electrical and thermal disturbance provoked by a metal intracoronary stent during epicardial pulsed electric field ablation. J Cardiovasc Dev Dis. 2022. Dic; 9(12):458. doi: 10.3390/jcdd9120458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Golberg A, Bruinsma BG, Uygun BE, Yarmush ML. Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by "electric field sinks". Sci Rep. 2015. Feb 16;5:8485. doi: 10.1038/srep08485 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Connolly A, Vigmond E, Bishop M. Virtual electrodes around anatomical structures and their roles in defibrillation. PLoS One. 2017. Mar 2;12(3):e0173324. doi: 10.1371/journal.pone.0173324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Higuchi S, Im SI, Stillson C, Buck ED, Jerrell S, Schneider CW, et al. Effect of Epicardial Pulsed Field Ablation Directly on Coronary Arteries. JACC Clin Electrophysiol. 2022. Dec;8(12):1486–1496. doi: 10.1016/j.jacep.2022.09.003 [DOI] [PubMed] [Google Scholar]
  • 33.Haines DE. What is different about pulsed-field ablation … everything? J Cardiovasc Electrophysiol. 2022. Mar;33(3):368–370. doi: 10.1111/jce.15353 [DOI] [PubMed] [Google Scholar]
  • 34.Anumonwo JMB, Herron T. Fatty Infiltration of the Myocardium and Arrhythmogenesis: Potential Cellular and Molecular Mechanisms. Front Physiol. 2018. Jan 22;9:2. doi: 10.3389/fphys.2018.00002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pop M, Molckovsky A, Chin L, Kolios MC, Jewett MA, Sherar MD. Changes in dielectric properties at 460 kHz of kidney and fat during heating: importance for radio-frequency thermal therapy. Phys Med Biol. 2003. Aug 7;48(15):2509–25. doi: 10.1088/0031-9155/48/15/317 [DOI] [PubMed] [Google Scholar]
  • 36.Guo F, Deng H, Qian K, Li X. Characterization of dispersion and anisotropic-conductivity in tissue model during electroporation pulses. Bioelectrochemistry. 2022. Apr;144:108029. doi: 10.1016/j.bioelechem.2021.108029 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Kadiam Venkata Subbaiah

5 May 2023

PONE-D-23-07892How intramyocardial fat can alter the electric field distribution during Pulsed Field Ablation (PFA): Qualitative findings from computer modelingPLOS ONE

Dear Dr. González-Suárez,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 19 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kadiam Venkata Subbaiah, Ph.D

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. Thank you for stating the following financial disclosure:

“Funded by the Spanish Ministerio de Ciencia e Innovación / Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) with Grant number PID2022-136273OB-C31 (JJP) and PID2022-136273OA-C33 (AGS).”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Dr. Ana González-Suárez,

I am pleased to inform you that the above-referenced manuscript is of interest and potentially acceptable for publication, but a minor revision is required to meet the concerns of the reviewers. The reviewers' comments are provided below.

Reviewer-1:

In this original article, Pérez and González-Suárez aimed to evaluate the effect of electrical impact of the

fat deposited in the ventricular scar during PFA by means of computer modeling. Computer

models were built considering a PFA 3.5-mm blunt-tip catheter in contact with a 7-mm

ventricular wall (with and without a scar) and a 2-mm epicardial fat layer. The authors should be congratulated on conducting such an important study. The design is fascinating and very inclusive with 6 different scenarios. They have found that intramyocardial fat can alter the electric field distribution positively resulting in deeper lesion size during PFA when compared with tissue without fat. This may be explained by its much lower electrical conductivity than myocardium and fibrotic tissue.

The paper is well written, very relevant to the field of electrophysiology, and very novel. Here are some minor comments:

1. Abbreviations: words should be abbreviated on their first mention and then the abbreviation should be used throughout the entire manuscript. For example in line 6 you say radiofrequency ablation without abbreviation, and then at the end of the introduction (I wished the lines were numbered, would have been easier) you use it abbreviated. But then again in the methods you use full wording; radiofrequency ablation. Please review the manuscript and try to be consistent while using all abbreviations.

2. In your conclusion you state that fat can alter the size. Alter can mean a negative impact (smaller size) and positive impact (bigger lesions). I would revise it to highlight that fat alters the lesions size "positively" resulting in deeper and wider lesions.

3. Fat is not only in the ventricle! The discussion and introduction somehow focus on VT, but that's a small portion of our patients. The majority of our patients are atrial fibrillation patients. Several studies have demonstrated the presence of endocardial and epicardial fat depositions within the atria of patients with atrial fibrillation. I would comment on that and make the paper less oriented to VT only.

Reviwer-2:

This article explores the potential influence of intramyocardial fat on the effects of PFA ablation; the work is based entirely on in silico data. The key finding of this study is that intramyocardial fat alters the distribution of the electric field in multiple ways – including a “shielding” effect of deeper structures as well as the creation of various “hot” and “cold” spots that effectively receive more and less ablative energy. Also notable is the finding that the shielding effect may persist despite current dose escalation.

The authors could significantly boost the relevance of this work by expanding the repertoire of myocardial models in addition to model “D.” In particular, it would be interesting to see how PFA performs in the context of various non-ischemic cardiomyopathies, some of which exhibit particularly strong propensity toward fibrofatty replacement (e.g. ARVC). At the very least, it would be helpful to explore other scenarios where the fatty layer is not essentially compact (as seen in model “D”) but more scattered. Would the same findings be encountered?

It is also important to note that this manuscript’s findings are generally NOT in line with the currently published data. This includes Younis at al. 2022 (PMID 36194542) which the authors cite and Higuchi et al. 2022 (PMID 36779624). While that does not mean that the findings of this work are incorrect, the authors should try to find a way to reconcile this difference. The authors do state that variations in PFA technology make comparisons difficult (p16), the basic “fat shielding” concept should presumably hold regardless of the pulse waveform, frequency and polarity (monopolar vs bipolar) used.

Reviewer-3:

The present study is based on a computer model built from realistic images of histological samples of the cardiac wall, which include intact myocardial tissue, infiltrated fat, and fibrotic tissue derived from a previous myocardial infarction. Despite the limitations inherent to any computer modeling study, the authors present interesting results that are difficult to obtain through in vivo or clinical experimentation. Although the conclusions regarding the impact of fibrosis have already been previously suggested in other studies, the conclusions regarding the impact of fat are novel but also controversial, since there are clinical studies that suggest that PFA would be capable of creating lesions through intramyocardial fat. While this may be true in some circumstances, the fact is that clinical and experimental studies inherently lack control over the real spatial distribution of fat, making it impossible to draw generic or biophysically based conclusions. In contrast, computer modeling based on physical laws of bioelectricity shows that fat has an important impact on the distribution of the electric field. For this reason I consider that the results of this study are novel, relevant and with a clinical impact because they encourage that more experimental studies should be carried out in order to determine the real potential of PFA on cardiac substrates that contain fat.

I have some comments about the manuscript which should be considered:

1) At present, there are different equipments to carry out electropolation of biological tissue, and each manufacturer has its own waveform protocol with its specific characteristics. The authors could suggest what impact the different protocols would have on their results and conclusions. For example, the use of bipolar versus monopolar protocols, or short (2 microseconds) versus long (100 microseconds) pulse widths.

2) There is also a current controversy in relation to how electroporation pulses could affect the electrical conduction system of the heart. Could the authors expand their discussion to include the possible impact of PFA on these types of tissues and its relation with the fat presence?

3) The authors solved a static electrical problem by ignoring the current transient that is generated when the pulses are applied. I suggest including an additional comment about how this could affect the conclusions of the study.

4) Although the authors justify that the spatial distributions of tissues shown in Fig. 2 are sufficiently representative of the clinical cases that can be found in PFA ablation, I wonder if there could be any case in which the electrode is situated almost directly on adipose tissue, and what would be the impact of this in the light of the results of the modeling study.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

Reviewer #3: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this original article, Pérez and González-Suárez aimed to evaluate the effect of electrical impact of the

fat deposited in the ventricular scar during PFA by means of computer modeling. Computer

models were built considering a PFA 3.5-mm blunt-tip catheter in contact with a 7-mm

ventricular wall (with and without a scar) and a 2-mm epicardial fat layer. The authors should be congratulated on conducting such an important study. The design is fascinating and very inclusive with 6 different scenarios. They have found that intramyocardial fat can alter the electric field distribution positively resulting in deeper lesion size during PFA when compared with tissue without fat. This may be explained by its much lower electrical conductivity than myocardium and fibrotic tissue.

The paper is well written, very relevant to the field of electrophysiology, and very novel. Here are some minor comments:

1. Abbreviations: words should be abbreviated on their first mention and then the abbreviation should be used throughout the entire manuscript. For example in line 6 you say radiofrequency ablation without abbreviation, and then at the end of the introduction (I wished the lines were numbered, would have been easier) you use it abbreviated. But then again in the methods you use full wording; radiofrequency ablation. Please review the manuscript and try to be consistent while using all abbreviations.

2. In your conclusion you state that fat can alter the size. Alter can mean a negative impact (smaller size) and positive impact (bigger lesions). I would revise it to highlight that fat alters the lesions size "positively" resulting in deeper and wider lesions.

3. Fat is not only in the ventricle! The discussion and introduction somehow focus on VT, but that's a small portion of our patients. The majority of our patients are atrial fibrillation patients. Several studies have demonstrated the presence of endocardial and epicardial fat depositions within the atria of patients with atrial fibrillation. I would comment on that and make the paper less oriented to VT only.

4.

Reviewer #2: This article explores the potential influence of intramyocardial fat on the effects of PFA ablation; the work is based entirely on in silico data. The key finding of this study is that intramyocardial fat alters the distribution of the electric field in multiple ways – including a “shielding” effect of deeper structures as well as the creation of various “hot” and “cold” spots that effectively receive more and less ablative energy. Also notable is the finding that the shielding effect may persist despite current dose escalation.

The authors could significantly boost the relevance of this work by expanding the repertoire of myocardial models in addition to model “D.” In particular, it would be interesting to see how PFA performs in the context of various non-ischemic cardiomyopathies, some of which exhibit particularly strong propensity toward fibrofatty replacement (e.g. ARVC). At the very least, it would be helpful to explore other scenarios where the fatty layer is not essentially compact (as seen in model “D”) but more scattered. Would the same findings be encountered?

It is also important to note that this manuscript’s findings are generally NOT in line with the currently published data. This includes Younis at al. 2022 (PMID 36194542) which the authors cite and Higuchi et al. 2022 (PMID 36779624). While that does not mean that the findings of this work are incorrect, the authors should try to find a way to reconcile this difference. The authors do state that variations in PFA technology make comparisons difficult (p16), the basic “fat shielding” concept should presumably hold regardless of the pulse waveform, frequency and polarity (monopolar vs bipolar) used.

Reviewer #3: The present study is based on a computer model built from realistic images of histological samples of the cardiac wall, which include intact myocardial tissue, infiltrated fat, and fibrotic tissue derived from a previous myocardial infarction. Despite the limitations inherent to any computer modeling study, the authors present interesting results that are difficult to obtain through in vivo or clinical experimentation. Although the conclusions regarding the impact of fibrosis have already been previously suggested in other studies, the conclusions regarding the impact of fat are novel but also controversial, since there are clinical studies that suggest that PFA would be capable of creating lesions through intramyocardial fat. While this may be true in some circumstances, the fact is that clinical and experimental studies inherently lack control over the real spatial distribution of fat, making it impossible to draw generic or biophysically based conclusions. In contrast, computer modeling based on physical laws of bioelectricity shows that fat has an important impact on the distribution of the electric field. For this reason I consider that the results of this study are novel, relevant and with a clinical impact because they encourage that more experimental studies should be carried out in order to determine the real potential of PFA on cardiac substrates that contain fat.

I have some comments about the manuscript which should be considered:

1) At present, there are different equipments to carry out electropolation of biological tissue, and each manufacturer has its own waveform protocol with its specific characteristics. The authors could suggest what impact the different protocols would have on their results and conclusions. For example, the use of bipolar versus monopolar protocols, or short (2 microseconds) versus long (100 microseconds) pulse widths.

2) There is also a current controversy in relation to how electroporation pulses could affect the electrical conduction system of the heart. Could the authors expand their discussion to include the possible impact of PFA on these types of tissues and its relation with the fat presence?

3) The authors solved a static electrical problem by ignoring the current transient that is generated when the pulses are applied. I suggest including an additional comment about how this could affect the conclusions of the study.

4) Although the authors justify that the spatial distributions of tissues shown in Fig. 2 are sufficiently representative of the clinical cases that can be found in PFA ablation, I wonder if there could be any case in which the electrode is situated almost directly on adipose tissue, and what would be the impact of this in the light of the results of the modeling study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Arwa Younis

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Nov 2;18(11):e0287614. doi: 10.1371/journal.pone.0287614.r002

Author response to Decision Letter 0


2 Jun 2023

RESPONSE TO REVIEWERS

Manuscript title: How intramyocardial fat can alter the electric field distribution during Pulsed Field Ablation (PFA): Qualitative findings from computer modeling

Authors: Juan J. Pérez, Ana González-Suárez

ID manuscript: PONE-D-23-07892

The following are the individual responses to the reviewers’ comments and explain how the revised version of the manuscript has been changed accordingly. The new text is in red in the revised version.

===========================================================

REVIEWER #1

===========================================================

COMMENT #1: “Abbreviations: words should be abbreviated on their first mention and then the abbreviation should be used throughout the entire manuscript. For example in line 6 you say radiofrequency ablation without abbreviation, and then at the end of the introduction (I wished the lines were numbered, would have been easier) you use it abbreviated. But then again in the methods you use full wording; radiofrequency ablation. Please review the manuscript and try to be consistent while using all abbreviations.”

Change in manuscript: Done.

COMMENT #2: “In your conclusion you state that fat can alter the size. Alter can mean a negative impact (smaller size) and positive impact (bigger lesions). I would revise it to highlight that fat alters the lesions size "positively" resulting in deeper and wider lesions.”

Response: In the light of our results, we do not think that the presence of fat always has a positive impact, but that the effect will depend on the spatial distribution of fat in each case and its relative position with respect to the ablation electrode. As pointed out in the Discussion, under some circumstances the fat could prevent damage to deeper tissues, maintaining a constant depth even as the current increases. As we have emphasized, fat constitutes an attractor for high electric field values, creating consequently low values in adjacent tissues (myocardium or fibrosis). This implies that the electric field might be considerably reduced in the myocardium located between the ablation electrode and a relatively deep area of fat, which would have a negative impact in terms of a smaller lesion depth than the absence of fat (e.g. compare the red and blue lines in Fig. 7B at a depth of 1.5 mm).The opposite can also occur, as suggested by Fig. 3, where the lesion is greater in the presence of fat.

Change in manuscript: We understand the reviewer's concern about sending a message in terms of clinical applicability. However, our conclusions were established mainly in terms of the physical description of the phenomenon and not so much of the advantage or disadvantage of the presence of fat. We have added a sentence indicating that the variation in lesion size due to the presence of fat will itself depend on the spatial distribution of the fat and its position relative to the electrode (see subsection “Comparison with experimental results and clinical implications”).

COMMENT #3: “Fat is not only in the ventricle! The discussion and introduction somehow focus on VT, but that's a small portion of our patients. The majority of our patients are atrial fibrillation patients. Several studies have demonstrated the presence of endocardial and epicardial fat depositions within the atria of patients with atrial fibrillation. I would comment on that and make the paper less oriented to VT only.”

Change in manuscript: We have reoriented the Introduction, Methods and Discussion towards the general effect of fat during PFA, by considering both fat in the epicardium (with important implications for ablation of atrial fibrillation) and intramyocardial fat, i.e. deposited in the subendocardium zone, caused by a post-myocardial infarction scar or by other causes, such as cardiomyopathy [1].

References

1. Wang B, Wan X, Li Y, Xie M. Endocardial fibrosis complicated with a great amount of fat accumulation in subendocardium: a rare form of restrictive cardiomyopathy. Eur Heart J. 2019 Jun 1;40(21):1740-1741. doi: 10.1093/eurheartj/ehz162. PMID: 30907414.

===========================================================

REVIEWER #2

===========================================================

COMMENT #1: “The authors could significantly boost the relevance of this work by expanding the repertoire of myocardial models in addition to model “D.” In particular, it would be interesting to see how PFA performs in the context of various non-ischemic cardiomyopathies, some of which exhibit particularly strong propensity toward fibrofatty replacement (e.g. ARVC). At the very least, it would be helpful to explore other scenarios where the fatty layer is not essentially compact (as seen in model “D”) but more scattered. Would the same findings be encountered?”

Response: This is an extremely interesting point since not only the presence of infiltrated fat in the myocardium is considered arrhythmogenic [1], and hence a potential target for PFA, but also the spatial distribution of infiltrated fat is highly dependent on the specific disease, as you mention. While fatty infiltration tends to be compact in myocardial infarction, it appears more dispersed in the case of arrhythmogenic right ventricular cardiomyopathy [1]. Note that our mathematical framework is based on physical laws (Laplace’s equation, in this case) which are valid regardless of the specific fat distribution considered. In this regard, note that although our model “D” was initially inspired by a histological image derived from a post-infarction scar [2], it also includes specific zones in which the fat appears patchy, i.e. more dispersed and separated by fibrotic tissue (see detail in Fig. 5A). It does not seem to be necessary to modify/expand the model “D” to mimic scattered fat.

Interestingly, it is precisely around these small zones of scattered fat where the electric field is significantly altered depending on the relative position of the ablation electrode, or what is the same, on the direction of the electric current, as shown in Fig. 5B. In conclusion, what our results suggest is that when the fat is in the form of isolated areas (see detail in Fig. 5A), such as those found in some non-ischemic cardiomyopathies, the alternation of ‘hot and cold points’ in the contiguous tissue in terms of electric field strength could compromise the efficacy of PFA of arrhythmogenic foci around the fat.

Change in manuscript: This comment has been added in the Discussion.

COMMENT #2: “It is also important to note that this manuscript’s findings are generally NOT in line with the currently published data. This includes Younis at al. 2022 (PMID 36194542) which the authors cite and Higuchi et al. 2022 (PMID 36779624). While that does not mean that the findings of this work are incorrect, the authors should try to find a way to reconcile this difference.”

Response: As mentioned, in addition to the few experimental results available, there is a discrepancy between the technologies used. For instance, while we modeled a standard-tip catheter, Younis et al [3] conducted monopolar PFA using a relatively large spherical electrode (Sphere-9, Affera, Inc), and Higuchi et al [4] conducted bipolar PFA using 4 band electrodes placed on an 8Fr catheter (Farapulse). Although these studies are by no means conclusive, they suggest that the effect of PFA extends from the subendocardium through collagen and fat to the epicardial layers, at least more effectively than RFA.

Despite the fact that our results suggest that the presence of fat alters the electric field value in its surroundings (acting as an attractor for a high electric field value), its effect does not have to be understood as a limitation in terms of lesion size: Although it is true that in some circumstances the presence of fat prevents the lesion from increasing in size as the administered electrical current increases (Fig. 4), this does not prevent the depth of the lesion from being deeper, even with fat than without fat (see Fig. 3), which is in line with the few experimental studies published to date. In qualitative terms, the presence of fat in deep areas ‘tends to enlarge’ the lesion size (Fig. 7).

Change in manuscript: This comment has been added to the Discussion to explain the differences between our results and the published data.

COMMENT #3: “The authors do state that variations in PFA technology make comparisons difficult (p16), the basic “fat shielding” concept should presumably hold regardless of the pulse waveform, frequency and polarity (monopolar vs bipolar) used.”

Response: Completely agree. The concepts derived from the computational results on how fat alters the electric field should be valid regardless of the technical details of PFA (electrode design, waveform, timing, polarity, etc.). However, our results do suggest that some of these details (such as electrode design and polarity) could be relevant in determining whether a specific fat distribution will favor or limit the lesion size and therefore whether PFA will achieve the target.

Change in manuscript: The comment on this point has been expanded with this information.

References

1. Anumonwo JMB, Herron T. Fatty Infiltration of the Myocardium and Arrhythmogenesis: Potential Cellular and Molecular Mechanisms. Front Physiol. 2018 Jan 22;9:2. doi: 10.3389/fphys.2018.00002. PMID: 29403390; PMCID: PMC5786512.

2. Sasaki T, Calkins H, Miller CF, Zviman MM, Zipunnikov V, Arai T, Sawabe M, Terashima M, Marine JE, Berger RD, Nazarian S, Zimmerman SL: New insight into scar-related ventricular tachycardia circuits in ischemic cardiomyopathy: Fat deposition after myocardial infarction on computed tomography—A pilot study. Heart Rhythm 2015;12:1508-1518.

3. Younis A, Zilberman I, Krywanczyk A, Higuchi K, Yavin HD, Sroubek J, Anter E. Effect of Pulsed-Field and Radiofrequency Ablation on Heterogeneous Ventricular Scar in a Swine Model of Healed Myocardial Infarction. Circ Arrhythm Electrophysiol. 2022 Oct;15(10):e011209. doi: 10.1161/CIRCEP.122.011209. Epub 2022 Oct 4. PMID: 36194542.

4. Higuchi S, Im SI, Stillson C, Buck ED, Jerrell S, Schneider CW, Speltz M, Gerstenfeld EP. Effect of Epicardial Pulsed Field Ablation Directly on Coronary Arteries. JACC Clin Electrophysiol. 2022 Dec;8(12):1486-1496. doi: 10.1016/j.jacep.2022.09.003. Epub 2022 Oct 26. PMID: 36779624.

===========================================================

REVIEWER #3

===========================================================

COMMENT #1: “At present, there are different equipments to carry out electropolation of biological tissue, and each manufacturer has its own waveform protocol with its specific characteristics. The authors could suggest what impact the different protocols would have on their results and conclusions. For example, the use of bipolar versus monopolar protocols, or short (2 microseconds) versus long (100 microseconds) pulse widths.”

Response: As mentioned by the reviewer, each PFA generator has different technical specifications. The differences in protocol in terms of peak voltage, pulse duration and amount, timing of the bursts, polarity, etc. will impact the lethal threshold of electric field strength. Overall, the higher the energy (accumulated duration x peak voltage) the lower the lethal threshold. Moreover, the frequency (related to pulse duration) will affect the risk of electrical stimulation and thermal side-effects. Despite this, our conclusions on the impact of fat and the appearance of ‘hot and cold points’ will remain unchanged.

Change in manuscript: A comment on this point has been added to the Discussion (see also Comment #3 of Reviewer #2).

COMMENT #2: “There is also a current controversy in relation to how electroporation pulses could affect the electrical conduction system of the heart. Could the authors expand their discussion to include the possible impact of PFA on these types of tissues and its relation with the fat presence?”

Response: Although this is certainly an interesting issue, it is outside the scope of our current study. Note that our computer model considers only the differences in electrical conductivity between the tissues involved and not their vulnerability in terms of being electroporated by a given protocol. In this regard, future computer modeling studies could be planned by considering the presence of the cells responsible for the electrical conduction system in the same way we considered fat deposition in our model. Unfortunately, information on the electrical characterization (passive electrical properties) of these tissues is still very scarce.

COMMENT #3: “The authors solved a static electrical problem by ignoring the current transient that is generated when the pulses are applied. I suggest including an additional comment about how this could affect the conclusions of the study.”

Change in manuscript: During PFA there is an extra current demand involved in charging and discharging the cell membranes. If the PFA generator is properly designed, it must be capable of managing the extra current demanded without altering the value of the voltage during the pulse. In our study we assumed that the generator is sized to distribute constant current. These issues are highly dependent on the technical characteristics of individual generators and manufacturers, and in any case do not affect the conclusions of the study.

COMMENT #4: “Although the authors justify that the spatial distributions of tissues shown in Fig. 2 are sufficiently representative of the clinical cases that can be found in PFA ablation, I wonder if there could be any case in which the electrode is situated almost directly on adipose tissue, and what would be the impact of this in the light of the results of the modeling study.”

Response: This is an interesting point. As intramyocardial fat is usually infiltrated in subendocardial areas it does not seem reasonable to assume a direct fat/electrode contact in an endocardial approach. However, it is possible to find this condition during epicardial PFA. This approach is less usual than endovascular and is conducted with the minimal surgical incisions [1]. In a previous modeling study we already reported that the epicardial fat layer notably ‘trapped’ the electrical field around the electrode, drastically reducing the values beyond this layer, i.e. in the myocardial tissue.

References

1. González-Suárez A, O'Brien B, O'Halloran M, Elahi A. Pulsed Electric Field Ablation of Epicardial Autonomic Ganglia: Computer Analysis of Monopolar Electric Field across the Tissues Involved. Bioengineering (Basel). 2022 Nov 27;9(12):731. doi: 10.3390/bioengineering9120731. PMID: 36550937; PMCID: PMC9774172.

Attachment

Submitted filename: Response to Reviewers.DOC

Decision Letter 1

Kadiam Venkata Subbaiah

8 Jun 2023

How intramyocardial fat can alter the electric field distribution during Pulsed Field Ablation (PFA): Qualitative findings from computer modeling

PONE-D-23-07892R1

Dear Dr.Ana González-Suárez,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kadiam Venkata Subbaiah, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Kadiam Venkata Subbaiah

14 Jun 2023

PONE-D-23-07892R1

How intramyocardial fat can alter the electric field distribution during Pulsed Field Ablation (PFA): Qualitative findings from computer modeling

Dear Dr. González-Suárez:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kadiam Venkata Subbaiah

Academic Editor

PLOS ONE


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES